<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2A89CBAF-C6DD-4A65-8618-D2ADFFA8CA9B"><gtr:id>2A89CBAF-C6DD-4A65-8618-D2ADFFA8CA9B</gtr:id><gtr:firstName>Shazia</gtr:firstName><gtr:surname>Chaudhry</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F3AF47FC-52EA-49D6-8520-F63D45185E65"><gtr:id>F3AF47FC-52EA-49D6-8520-F63D45185E65</gtr:id><gtr:firstName>Cay</gtr:firstName><gtr:surname>Kielty</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0601946"><gtr:id>C7276A27-59CA-445E-A973-32A50E7355DA</gtr:id><gtr:title>Fibrillin-1 regulation of TGFbeta bioavailability</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601946</gtr:grantReference><gtr:abstractText>Transforming growth factor (TGF) beta is a potent growth factor that regulates cell survival, proliferation, migration and differentiation. Understanding TGFbeta signalling dysregulation in severe heritable diseases such as Marfan syndrome, and in chronic fibrotic disorders such as sclerosis is a major challenge in the search for effective therapies. We have discovered that fibrillin-1 regulates TGFbeta1 bioavailability by releasing latent TGFbeta from the extracellular matrix. This application is to build on, and exploit our discovery that the extracellular matrix molecule fibrillin-1 regulates TGFbeta bioavailability. We will resolve the molecular basis of how fibrillins regulate TGFbeta, and how we can exploit this knowledge therapeutically. Outcomes will be new insights into how TGFbeta is regulated by the extracellular matrix, and new therapeutic strategies to regulate TGFbeta bioavailability in health and disease.</gtr:abstractText><gtr:technicalSummary>Transforming growth factor (TGF)beta is a potent growth factor that regulates cell survival, proliferation, migration and differentiation. Understanding TGFbeta signalling dysregulation in Marfan syndrome and related heritable diseases, and in chronic fibrotic disorders such as sclerosis is a major challenge in the search for effective therapies. We have discovered that fibrillin-1 regulates TGFbeta1 bioavailability by releasing latent TGFbeta from the extracellular matrix. This proposal is to resolve the molecular basis of how fibrillins regulate TGFbeta, and how to exploit this knowledge therapeutically.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>491776</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminars at European Institutions</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E1C9AF4-AF4E-4AC7-B8AD-729999FFA49A</gtr:id><gtr:impact>2007 Lund, Sweden (elastic fibres)
2009 Copenhagen University (elastic fibres)

Collaborative links.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust PhD studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>1C42CE56-50A6-47C2-93A7-5CF98C74F4D7</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a large panel of recombinant human elastic fibre proteins (including fibrillin-1, fibrillin-2, MAGP-1, fibulins 3-5, LTBPs 1 and 3, periostin).</gtr:description><gtr:id>34C48401-4BAB-41A0-9EBA-62F2E90F53BE</gtr:id><gtr:impact>Publications describing molecular interactions in elastic fibre assembly, and structural analyses of a number of these fragments by small-angle X-ray scattering and EM approaches (these structural studies were led by Dr C Baldock).</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Recombinant elastic fibre proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have a number of cell culture models to study elastic fibre deposition; they include primary human dermal fibroblasts and the ARPE-19 cell line; we have also developed robust siRNA and shRNA approaches for knockdowns, and retroviral knock-in approaches in these cultures.</gtr:description><gtr:id>FB8C87B0-3CA0-4A59-A623-A873D8F6924E</gtr:id><gtr:impact>These cell lines are enabling us (a) to determine the molecular mechanisms underlying elastic fibre formation.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cell culture models for elastic fibre biology</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8783B368-25E4-4440-80FD-C4564C34B392"><gtr:id>8783B368-25E4-4440-80FD-C4564C34B392</gtr:id><gtr:title>Fibrillin-1 regulates the bioavailability of TGFbeta1.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8163626e54541756dae115e83f754135"><gtr:id>8163626e54541756dae115e83f754135</gtr:id><gtr:otherNames>Chaudhry SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71E38C04-1BBE-4BF9-BD17-4D69B250677B"><gtr:id>71E38C04-1BBE-4BF9-BD17-4D69B250677B</gtr:id><gtr:title>Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3bb6cca69f9b08daab1ced3119107e9d"><gtr:id>3bb6cca69f9b08daab1ced3119107e9d</gtr:id><gtr:otherNames>Massam-Wu T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601946</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>